Fresenius Medical Care: flat revenue, weaker profit and narrower 2026 guidance
Fresenius Medical Care kept third-quarter revenue broadly stable while profit fell, and narrowed its 2026 operating income guidance, per TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, Fresenius Medical Care's third-quarter revenue was broadly unchanged. Adjusted operating income and net income both declined year on year. Cash generation stayed solid, and profitability in the Care Delivery unit improved when TDAPA effects are excluded.
The company narrowed its full-year 2026 operating income guidance to a range from flat to a mid-single-digit decline. A separate report points to China strategy costs, regulatory pressure and inflation as drags on reported earnings, while Care Delivery and Care Enablement grew.
why it matters
Two points matter for the market: lower reported earnings driven by costs, and a narrower forecast that reduces uncertainty without signalling stronger growth. TDAPA pressure keeps profit under strain even where individual segments are expanding.
market impact
Fresenius Medical Care shares: lower earnings and a cautious outlook weigh on the stock
- Fresenius Medical Care shares pressure down — lower reported earnings and a cautious operating income outlook
tags
instruments
sources
- FME: Stable revenue, TDAPA-pressured earnings and narrowed FY 2026 guidance — TradingView, 3 November 2026 at 06:21 UTC
- FME: Stable organic revenue, lower reported earnings and narrowed FY operating income guidance — TradingView, 3 November 2026 at 06:42 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗